Form 8-K - Current report:
SEC Accession No. 0001193125-26-068813
Filing Date
2026-02-25
Accepted
2026-02-25 09:15:41
Documents
10
Period of Report
2026-02-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dcoy-20260224.htm   iXBRL 8-K 75939
  Complete submission text file 0001193125-26-068813.txt   191927

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dcoy-20260224.xsd EX-101.SCH 31319
13 EXTRACTED XBRL INSTANCE DOCUMENT dcoy-20260224_htm.xml XML 4706
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Decoy Therapeutics Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 26674591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)